Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P21
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -81.69% |
| Q3 2025 | -42.15% |
| Q2 2025 | 30.96% |
| Q1 2025 | 49.61% |
| Q4 2024 | -211.02% |
| Q3 2024 | 49.18% |
| Q2 2024 | 30.53% |
| Q1 2024 | -66.44% |
| Q4 2023 | 5.40% |
| Q3 2023 | 65.12% |
| Q2 2023 | -475.29% |
| Q1 2023 | -87.85% |
| Q4 2022 | 429.97% |
| Q3 2022 | -66.63% |
| Q2 2022 | 56.15% |
| Q1 2022 | -33.83% |
| Q4 2021 | 30.06% |
| Q3 2021 | -0.19% |
| Q2 2021 | 6.84% |
| Q1 2021 | -85.53% |
| Q4 2020 | -48.45% |
| Q3 2020 | -108.50% |
| Q2 2020 | -6.13% |
| Q1 2020 | 12.53% |
| Q4 2019 | -42.03% |
| Q3 2019 | -1231.47% |
| Q2 2019 | 91.21% |
| Q1 2019 | -815.33% |
| Q4 2018 | 83.68% |
| Q3 2018 | 56.75% |
| Q2 2018 | -50.96% |
| Q1 2018 | -4533.33% |
| Q4 2017 | 95.02% |
| Q3 2017 | 24.35% |
| Q2 2017 | -5.23% |
| Q1 2017 | 40.37% |
| Q4 2016 | 23.11% |
| Q3 2016 | -33.90% |
| Q2 2016 | -13.11% |
| Q1 2016 | -5.19% |